ERLEADA® (apalutamide) Significantly Improved Overall Survival (OS) and Radiographic Progression-Free Survival (rPFS) in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Phase 3 results featured in oral presentation at ASCO 2019, selected for Best of ASCO 2019 Meetings, and simultaneously published in The New England Journal of Medicine. CHICAGO May 31, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today findings from the....

Posted: 2019-06-01 00:34:00

Read Full Article

< Prev		Next >

Donate now!

Donate now, contribute to EGR & NEXUS-IBA projects

Free consultation

If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.

We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.

EGR local time

Verse of the day

For many are called, but few are chosen. Matthew, 22. 14

Main Menu

Polls

Is wealth an indication of God’s favor or blessing?

	Yes
	No
	Somehow
	I do not know

EGR European Gospel Radio